Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-19 Purchase | 2023-09-21 5:10 pm | RayzeBio Inc. | RYZB | Katabi Maha Director | 472,222 | $18 | $8,499,996 | 1,209,764 (Indirect) | View |
| 2023-09-19 Purchase | 2023-09-21 5:00 pm | RayzeBio Inc. | RYZB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities Drawdown GP LLC Viking Global Opportunities Drawdown Portfolio GP LLC Viking Global Opportunities Drawdown (Aggregator) LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 1,388,889 | $18 | $25,000,002 | 1,743,556 (Indirect) | View |
| 2023-09-19 Purchase | 2023-09-21 4:59 pm | RayzeBio Inc. | RYZB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 1,388,889 | $18 | $25,000,002 | 1,743,556 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-26 Other | 2024-02-28 4:30 pm | N/A N/A | RayzeBio Inc. | RYZB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities Drawdown GP LLC Viking Global Opportunities Drawdown Portfolio GP LLC Viking Global Opportunities Drawdown (Aggregator) LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 6,642,700 | $0 | 6,642,700 (Indirect) | View |
| 2024-02-26 Other | 2024-02-28 4:28 pm | N/A N/A | RayzeBio Inc. | RYZB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 6,642,700 | $0 | 6,642,700 (Indirect) | View |
| 2024-02-26 Disposition | 2024-02-27 5:14 pm | N/A 2033-08-21 | RayzeBio Inc. | RYZB | Oliger Christy J. Director | 114,579 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 5:10 pm | N/A 2032-03-21 | RayzeBio Inc. | RYZB | You Angie Director | 114,579 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 5:07 pm | N/A 2033-10-31 | RayzeBio Inc. | RYZB | Van Hauwermeiren Timothy Director | 48,628 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 5:04 pm | N/A 2031-09-28 | RayzeBio Inc. | RYZB | TAGLIAFERRI MARY Director | 114,579 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:59 pm | N/A N/A | RayzeBio Inc. | RYZB | Heyman Richard A. Director | 367,446 | $62.5 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:51 pm | N/A 2031-03-18 | RayzeBio Inc. | RYZB | Larson Yi Director | 114,579 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:47 pm | N/A 2033-11-16 | RayzeBio Inc. | RYZB | Katabi Maha Director | 18,235 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:47 pm | N/A N/A | RayzeBio Inc. | RYZB | Katabi Maha Director | 1,209,764 | $62.5 | 0 (Indirect) | View |
| 2024-02-26 Disposition | 2024-02-27 4:45 pm | N/A 2031-09-28 | RayzeBio Inc. | RYZB | Moran Susan CHIEF MEDICAL OFFICER | 497,076 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:45 pm | N/A N/A | RayzeBio Inc. | RYZB | Moran Susan CHIEF MEDICAL OFFICER | 323,455 | $62.5 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:42 pm | N/A 2031-12-14 | RayzeBio Inc. | RYZB | Kush Arvind CHIEF FINANCIAL OFFICER | 615,522 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:42 pm | N/A N/A | RayzeBio Inc. | RYZB | Kush Arvind CHIEF FINANCIAL OFFICER | 78,433 | $62.5 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:41 pm | N/A 2032-11-30 | RayzeBio Inc. | RYZB | SONG KENNETH PRESIDENT AND CHIEF EXECUTIVE | 1,353,370 | $0 | 0 (Indirect) | View |
| 2024-02-26 Disposition | 2024-02-27 4:41 pm | N/A N/A | RayzeBio Inc. | RYZB | SONG KENNETH PRESIDENT AND CHIEF EXECUTIVE | 1,622,968 | $62.5 | 0 (Indirect) | View |
| 2024-01-22 Exercise | 2024-02-06 6:11 pm | N/A N/A | RayzeBio Inc. | RYZB | Moran Susan CHIEF MEDICAL OFFICER | 30,875 | $3.24 | 383,404 (Direct) | View |
| 2024-01-22 Exercise | 2024-02-06 6:11 pm | N/A 2031-09-28 | RayzeBio Inc. | RYZB | Moran Susan CHIEF MEDICAL OFFICER | 30,875 | $0 | 383,404 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-17 6:38 pm | N/A 2033-11-16 | RayzeBio Inc. | RYZB | Kush Arvind Chief Financial Officer | 164,000 | $0 | 164,000 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-17 6:38 pm | N/A 2033-11-16 | RayzeBio Inc. | RYZB | SONG KENNETH President and Chief Executive | 480,000 | $0 | 480,000 (Indirect) | View |
| 2023-11-17 Option Award | 2023-11-17 6:37 pm | N/A 2033-11-16 | RayzeBio Inc. | RYZB | Katabi Maha Director | 18,235 | $0 | 18,235 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-17 6:36 pm | N/A 2033-11-16 | RayzeBio Inc. | RYZB | Moran Susan Chief Medical Officer | 164,000 | $0 | 164,000 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-01 4:09 pm | N/A 2033-10-31 | RayzeBio Inc. | RYZB | Van Hauwermeiren Timothy Director | 48,628 | $0 | 48,628 (Direct) | View |
| 2023-09-19 Conversion | 2023-09-21 9:30 pm | N/A N/A | RayzeBio Inc. | RYZB | Redmile Group LLC Green Jeremy Redmile Biopharma Investments II L.P. 10% Owner | 2,289,960 | $0 | 1,857,706 (Indirect) | View |
| 2023-09-19 Conversion | 2023-09-21 5:10 pm | N/A N/A | RayzeBio Inc. | RYZB | Katabi Maha Director | 1,947,306 | $0 | 1,209,764 (Indirect) | View |
| 2023-09-19 Conversion | 2023-09-21 5:00 pm | N/A N/A | RayzeBio Inc. | RYZB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities Drawdown GP LLC Viking Global Opportunities Drawdown Portfolio GP LLC Viking Global Opportunities Drawdown (Aggregator) LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 5,686,065 | $0 | 1,743,556 (Indirect) | View |
| 2023-09-19 Conversion | 2023-09-21 4:59 pm | N/A N/A | RayzeBio Inc. | RYZB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 5,686,065 | $0 | 1,743,556 (Indirect) | View |
| 2023-09-19 Conversion | 2023-09-21 4:30 pm | N/A N/A | RayzeBio Inc. | RYZB | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 5,374,289 | $0 | 5,158,162 (Direct) | View |
| 2023-09-19 Conversion | 2023-09-19 7:41 pm | N/A N/A | RayzeBio Inc. | RYZB | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner | 1,557,846 | $0 | 1,557,846 (Direct) | View |
Ownership | 2023-09-14 9:45 pm | N/A N/A | RayzeBio Inc. | RYZB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities Drawdown GP LLC Viking Global Opportunities Drawdown Portfolio GP LLC Viking Global Opportunities Drawdown (Aggregator) LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 0 | $0 | 5,253,811 (Indirect) | View |
Ownership | 2023-09-14 9:44 pm | N/A N/A | RayzeBio Inc. | RYZB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 0 | $0 | 5,253,811 (Indirect) | View |
Ownership | 2023-09-14 9:31 pm | N/A N/A | RayzeBio Inc. | RYZB | Redmile Group LLC Green Jeremy Redmile Biopharma Investments II L.P. 10% Owner | 0 | $0 | 1,857,706 (Indirect) | View |
Ownership | 2023-09-14 9:17 pm | N/A N/A | RayzeBio Inc. | RYZB | Versant Ventures VII GP-GP LLC Versant Ventures VII GP L.P. Versant Venture Capital VII L.P. Versant Vantage I GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I L.P. 10% Owner | 0 | $0 | 5,158,161 (Indirect) | View |
Ownership | 2023-09-14 8:37 pm | N/A N/A | RayzeBio Inc. | RYZB | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 0 | $0 | 5,158,162 (Direct) | View |
Ownership | 2023-09-14 7:51 pm | N/A N/A | RayzeBio Inc. | RYZB | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner | 0 | $0 | 1,557,846 (Direct) | View |
Ownership | 2023-09-14 7:39 pm | N/A N/A | RayzeBio Inc. | RYZB | Kush Arvind Chief Financial Officer | 0 | $0 | 529,079 (Direct) | View |
Ownership | 2023-09-14 7:37 pm | N/A N/A | RayzeBio Inc. | RYZB | Moran Susan Chief Medical Officer | 0 | $0 | 655,723 (Direct) | View |
Ownership | 2023-09-14 7:36 pm | N/A N/A | RayzeBio Inc. | RYZB | SONG KENNETH President and Chief Executive | 0 | $0 | 2,495,465 (Indirect) | View |
Ownership | 2023-09-14 7:32 pm | N/A 2032-03-21 | RayzeBio Inc. | RYZB | You Angie Director | 0 | $0 | 114,579 (Direct) | View |
Ownership | 2023-09-14 7:31 pm | N/A 2031-09-28 | RayzeBio Inc. | RYZB | TAGLIAFERRI MARY Director | 0 | $0 | 114,579 (Direct) | View |
Ownership | 2023-09-14 7:28 pm | N/A 2033-08-21 | RayzeBio Inc. | RYZB | Oliger Christy J. Director | 0 | $0 | 114,579 (Direct) | View |
Ownership | 2023-09-14 7:27 pm | N/A 2031-03-18 | RayzeBio Inc. | RYZB | Larson Yi Director | 0 | $0 | 114,579 (Direct) | View |
Ownership | 2023-09-14 7:27 pm | N/A N/A | RayzeBio Inc. | RYZB | Katabi Maha Director | 0 | $0 | 1,947,306 (Indirect) | View |